|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 886.6 DKK | +2.28% |
|
+2.36% | +27.00% |
| Apr. 25 | NOVO NORDISK : JP Morgan gives a Buy rating | ZD |
| Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
By Dominic Chopping
Novo Nordisk is buying Cardior Pharmaceuticals for up to $1.03 billion euros ($1.11 billion) as it moves to strengthen its pipeline of drugs to treat cardiovascular disease and expand into areas outside of its core diabetes and weight-loss market.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
03-25-24 0631ET
| 1st Jan change | Capi. | |
|---|---|---|
| +27.00% | 566B | |
| +25.83% | 661B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B | |
| -11.77% | 144B |
NOVO NORDISK A/S 
